Inactive Instrument

Modern Mobility Aids, Inc. Stock Other OTC

Equities

MDRM

US6076741080

Sales 2013 - Sales 2014 - Capitalization 10.79M
Net income 2013 - Net income 2014 - EV / Sales 2013 -
Net Debt 2013 361K Net Debt 2014 606K EV / Sales 2014 -
P/E ratio 2013
-7.81 x
P/E ratio 2014
-71.1 x
Employees -
Yield 2013 *
-
Yield 2014
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Odern Mobility Aids, Inc. Appoints Dr. Zakiuddin Ahmed, as President CI
Galileo Life Sciences Inc Continues Development of Its Telehealth Business Model and Announces an Opening Date for Its 'Vcplus Clinics' in October 2021 CI
Galileo Life Sciences, Inc. has Changed its Name to Modern Mobility Aids, Inc CI
Galileo Life Sciences, Inc. cancelled the acquisition of Novo Healthnet Limited. CI
Galileo Life Sciences, Inc. agreed to acquire Novo Healthnet Limited. CI
Modern Mobility Aids, Inc. completed the acquisition of 50% stake in Green Calyx, Inc. from Newland family group of companies. CI
Modern Mobility Aids, Inc. Announces Executive Changes CI
Modern Mobility Aids, Inc. Announces Appointment of Dr. Baseer Khan as Chief Medical Director CI
Modern Mobility Aids, Inc. entered into an agreement to acquire 50% stake in Green Calyx, Inc. from Newland family group of companies. CI
Modern Mobility Aids, Inc. Announces Resignation of Declan French as Director and Chairman CI
Modern Mobility Aids Inc. Appoints Ken Pinckard as Chief Executive Officer CI
Modern Mobility Aids, Inc. Appoints Peter J. Rothbart to its Medical Advisory Team CI
Modern Mobility Aids, Inc. Appoints Gilbert Sharpe as Executive Advisor CI
Modern Mobility Aids, Inc. Announces Executive Changes CI
Modern Mobility Aids, Inc. Appoints Preston Shea as Director and President CI
More news
Managers TitleAgeSince
Chief Executive Officer 75 17-02-27
President - 23-10-30
Comptroller/Controller/Auditor 76 14-02-23
Members of the board TitleAgeSince
Chairman 81 17-02-23
Comptroller/Controller/Auditor 76 14-02-23
Chief Executive Officer 75 17-02-27
More insiders
Modern Mobility Aids Inc., formerly Galileo Life Sciences, Inc., is focused on the life sciences and healthcare industry. The Company is focused on acquiring companies within the biopharmaceutical sector, to focus research and development, and to create a manufacturing capacity in the three segments, which include contract research and manufacturing for life sciences companies, drug and device delivery format packaging and strategic development and production alliances. The Company plans to acquire or invest in multiple licensed producers in Canada and the United States. The Company is focused on exploiting the opportunities presented in the medical marijuana arena. The Company's subsidiary is MDRM Group (Canada) Ltd. The Company also focuses on investing in licensed producers in Canada and the United States, as well as suppliers to the industry. The Company has not generated any revenues and had not commenced any revenue generating activities.
Sector
-
More about the company